Switzerland on Monday authorised Moderna’s Covid-19 vaccine for kids aged between 12 and 17 years previous, weeks after EU regulators authorised the drug for a similar age group.
The Swissmedic regulatory authority, which has already authorised the Pfizer-BioNTech jab for over-12s, stated outcomes from an ongoing examine confirmed Moderna had 93 p.c efficacy within the younger age group.
“The vaccine produced an identical immune response… on this examine in comparison with younger adults aged 18 to 25 years,” the regulator stated.
Switzerland, which isn’t within the European Union, has its personal regulatory course of and was the primary nation in continental Europe to begin utilizing the Pfizer-BioNTech jab.
The nation has doled out greater than 9.1 million doses and almost 49.2 p.c of the inhabitants of 8.6 million at the moment are absolutely vaccinated.
Nonetheless, take-up has slowed in latest weeks. Practically 2.5 million doses had been administered in June however fewer than 1.4 million in July.
The virus has killed 10,354 folks in Switzerland and 723,907 constructive exams have been registered.
Moderna’s Covid-19 jab is utilized in 48 nations, behind AstraZeneca (161), Pfizer-BioNTech (88) and Sinopharm (49), based on an AFP rely.
(Aside from the headline, this story has not been edited by NDTV employees and is revealed from a syndicated feed.)